Osteoclasts: more than 'bone eaters'

被引:421
作者
Charles, Julia F.
Aliprantis, Antonios O. [1 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
osteoclast; osteoblast; bone remodeling; osteopetrosis; osteoporosis; PTH; COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELL; AUTOSOMAL RECESSIVE OSTEOPETROSIS; PARATHYROID-HORMONE PTH; SUPPRESSOR-CELLS; GROWTH-FACTOR; POSTMENOPAUSAL WOMEN; RECEPTOR ACTIVATOR; ZOLEDRONIC ACID; MINERAL DENSITY;
D O I
10.1016/j.molmed.2014.06.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
As the only cells definitively shown to degrade bone, osteoclasts are key mediators of skeletal diseases including osteoporosis. Bone-forming osteoblasts, and hematopoietic and immune system cells, each influence osteoclast formation and function, but the reciprocal impact of osteoclasts on these cells is less well appreciated. We highlight here the functions that osteoclasts perform beyond bone resorption. First, we consider how osteoclast signals may contribute to bone formation by osteoblasts and to the pathology of bone lesions such as fibrous dysplasia and giant cell tumors. Second, we review the interaction of osteoclasts with the hematopoietic system, including the stem cell niche and adaptive immune cells. Connections between osteoclasts and other cells in the bone microenvironment are discussed within a clinically relevant framework.
引用
收藏
页码:449 / 459
页数:11
相关论文
共 132 条
[1]
Excess mortality following hip fracture: a systematic epidemiological review [J].
Abrahamsen, B. ;
van Staa, T. ;
Ariely, R. ;
Olson, M. ;
Cooper, C. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (10) :1633-1650
[2]
RANKL-RANK interaction in immune regulatory systems [J].
Akiyama, Taishin ;
Shinzawa, Miho ;
Akiyama, Nobuko .
WORLD JOURNAL OF ORTHOPEDICS, 2012, 3 (09) :142-150
[3]
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism [J].
Aliprantis, Antonios O. ;
Ueki, Yasuyoshi ;
Sulyanto, Rosalyn ;
Park, Arnold ;
Sigrist, Kirsten S. ;
Sharma, Sudarshana M. ;
Ostrowski, Michael C. ;
Olsen, Bjorn R. ;
Glimcher, Laurie H. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (11) :3775-3789
[4]
Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover [J].
Angel, NZ ;
Walsh, N ;
Forwood, MR ;
Ostrowski, MC ;
Cassady, AI ;
Hume, DA .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :103-110
[5]
[Anonymous], 2004, Bone Health and Osteoporosis: A report of the Surgeon General
[6]
CTLA-4 directly inhibits osteoclast formation [J].
Axmann, R. ;
Herman, S. ;
Zaiss, M. ;
Franz, S. ;
Polzer, K. ;
Zwerina, J. ;
Herrmann, M. ;
Smolen, J. ;
Schett, G. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) :1603-1609
[7]
Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone [J].
Balke, Maurice ;
Campanacci, Laura ;
Gebert, Carsten ;
Picci, Piero ;
Gibbons, Max ;
Taylor, Richard ;
Hogendoorn, Pancras ;
Kroep, Judith ;
Wass, John ;
Athanasou, Nicholas .
BMC CANCER, 2010, 10
[8]
WNT signaling in bone homeostasis and disease: from human mutations to treatments [J].
Baron, Roland ;
Kneissel, Michaela .
NATURE MEDICINE, 2013, 19 (02) :179-192
[9]
Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH [J].
Bedi, Brahmchetna ;
Li, Jau-Yi ;
Tawfeek, Hesham ;
Baek, Ki-Hyun ;
Adams, Jonathan ;
Vangara, Sameera S. ;
Chang, Ming-Kang ;
Kneissel, Michaela ;
Weitzmanna, M. Neale ;
Pacifici, Roberto .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (12) :E725-E733
[10]
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis [J].
Black, DM ;
Greenspan, SL ;
Ensrud, KE ;
Palermo, L ;
McGowan, JA ;
Lang, TF ;
Garnero, P ;
Bouxsein, ML ;
Bilezikian, JP ;
Rosen, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1207-1215